Synthetic Hype
By Jonathan Kahn,
Biopolitical Times guest contributor
| 12. 27. 2010
I've been thinking lately about the current excitement over the promise and potential of synthetic biology. The basic idea of synthetic biology is to make biology more like engineering, creating standardized biological "parts" that can be combined to redesign existing biological systems or create entirely new ones that do not already exist in the natural world. It is aptly represented by the concept of "biobricks," a
trademarked term describing "standard biological parts [that] a synthetic biologist or biological engineer can [use to] program living organisms in the same way a computer scientist can program a computer."
I am concerned because this seems to be the latest in a long line of grand promises that have accompanied demands for resources (both monetary and intellectual) for successive major biotechnological undertakings over the past twenty years. Each of these undertakings has been worthy in its own right but none has, as yet, come anywhere near to realizing the extravagant claims made by its initial promoters. Modern developments in biotechnology have been driven, in part, by an ever receding horizon of promise. Many scholars...
Related Articles
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
The title of this book is clever, not least because it is borrowed from a very secret society of a dozen Stanford students. Theo Baker, a gregarious computer science freshman, was interviewed by the hyper-rich anonymous entrepreneur who quietly assembled the members. The unspoken suggestion was that he might consider hiring some of the members in service of acquiring his next billion. (Either Baker was not offered a place or he is not admitting it.) Such are the ways of...
By Jan Grue, Boston Review | 06.17.2026
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...